Keywords: eisai, reports, progress, dementia, drug, japan, said

Eisai Reports Progress With Dementia Drug

Article | 02 October 1995

Print This

Eisai of Japan has said that its compound E2020 has shown "encouraging US Phase III clinical trials results" in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in